Patents Assigned to ABSCI, LLC
  • Patent number: 11584785
    Abstract: A connecting polypeptide has SEQ ID NO:73. A proinsulin polypeptide includes a mature insulin A-chain, a mature insulin B-chain, and a connecting peptide comprising SEQ ID NO: 73 linking the mature A-chain and the mature B-chain, wherein the connecting peptide is not a native human proinsulin C-peptide. The proinsulin polypeptides according to the invention can be made in high titers and in high purity.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: February 21, 2023
    Assignee: ABSCI, LLC
    Inventors: Amy Doerner, Michael Cammarata, Tyler Nusca, Suzanne A. Sprunger, Melissa Patterson
  • Patent number: 11447781
    Abstract: The present invention provides host cells for use in an inducible coexpression system that is capable of controlled induction of expression of each gene product.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: September 20, 2022
    Assignee: ABSCI LLC
    Inventors: Sean McClain, Mark Valasek
  • Patent number: 11371048
    Abstract: The present invention provides expression vectors for use in an inducible coexpression system, capable of controlled induction of expression of each gene product.
    Type: Grant
    Filed: September 11, 2016
    Date of Patent: June 28, 2022
    Assignee: ABSCI LLC
    Inventors: Sean McClain, Mark Valasek, Philip Barish, Jeremy Minshull
  • Publication number: 20200299343
    Abstract: A connecting polypeptide has SEQ ID NO:73. A proinsulin polypeptide includes a mature insulin A-chain, a mature insulin B-chain, and a connecting peptide comprising SEQ ID NO: 73 linking the mature A-chain and the mature B-chain, wherein the connecting peptide is not a native human proinsulin C-peptide. The proinsulin polypeptides according to the invention can be made in high titers and in high purity.
    Type: Application
    Filed: May 4, 2020
    Publication date: September 24, 2020
    Applicant: AbSci LLC
    Inventors: Amy Doerner, Michael Cammarata, Fred Larimore, Tyler Nusca, Suzanne A. Sprunger, Melissa Patterson
  • Publication number: 20200270338
    Abstract: A cell for producing insulin includes an E. coli host cell and a polynucleotide designed for production of insulin disposed within the E. coli host cell. The polynucleotide includes a first inducible promoter and a first coding sequence to be transcribed from the first inducible promoter, the first coding sequence encoding an insulin polypeptide. The polynucleotide also includes a second inducible promoter and a second coding sequence to be transcribed from the second inducible promoter, the second coding sequence encoding one or more of cDsbA, cDsbC, a protein disulfide isomerase, Ervlp, and a chaperone. The first inducible promoter and the second inducible promoter are not responsive to the same inducer. A method of producing insulin includes growing a sample of the cells in a fermentation volume between 0.1 L and 1,000,000 L, adding an inducer of the first inducible promoter to induce expression of the insulin polypeptide, and purifying the insulin polypeptide.
    Type: Application
    Filed: May 11, 2020
    Publication date: August 27, 2020
    Applicant: AbSci LLC
    Inventors: Sean McClain, Philip Barish
  • Publication number: 20200172915
    Abstract: The present invention provides host cells for use in an inducible coexpression system that is capable of controlled induction of expression of each gene product.
    Type: Application
    Filed: February 13, 2020
    Publication date: June 4, 2020
    Applicant: AbSci LLC
    Inventors: Sean McClain, Mark Valasek
  • Patent number: 10604761
    Abstract: The present invention provides host cells for use in an inducible coexpression system that is capable of controlled induction of expression of each gene product.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: March 31, 2020
    Assignee: AbSci LLC
    Inventors: Sean McClain, Mark Valasek
  • Publication number: 20200032276
    Abstract: The present invention is an inducible coexpression system, capable of controlled induction of expression of each gene product.
    Type: Application
    Filed: October 7, 2019
    Publication date: January 30, 2020
    Applicant: AbSci, LLC
    Inventors: Sean McClain, Mark Valasek
  • Patent number: 10508270
    Abstract: The present invention provides methods of producing thrombin using coordinated coexpression systems, and particularly inducible coexpression systems, capable of controlled induction of expression of each gene product required for the production of thrombin, and the thrombin produced by this method.
    Type: Grant
    Filed: February 5, 2014
    Date of Patent: December 17, 2019
    Assignees: AbSci LLC, Aronora Inc.
    Inventors: Sean McClain, Mark Valasek, Andras Gruber
  • Publication number: 20180282405
    Abstract: The present invention provides host cells having an oxidizing cytoplasm, which are capable of growing to high cell densities and producing recombinant proteins in soluble form. Also provided are methods for growing such host cells to high densities, methods for optionally modulating the growth rates of the host cells, and methods for inducing the host cells to produce the desired gene product in soluble form. Further aspects of the invention relate to host cell preparation and storage methods, which utilize the advantages of producing gene products in host cell cytoplasm to provide methods for long-term storage and/or transport of expressed gene products that are retained in a stable and soluble form within the host cells.
    Type: Application
    Filed: June 14, 2018
    Publication date: October 4, 2018
    Applicant: AbSci, LLC
    Inventors: Sean McClain, Philip Barish
  • Publication number: 20170159061
    Abstract: The present invention provides host cells for use in an inducible coexpression system that is capable of controlled induction of expression of each gene product.
    Type: Application
    Filed: February 16, 2017
    Publication date: June 8, 2017
    Applicant: AbSci, LLC
    Inventors: Sean McClain, Mark Valasek
  • Patent number: 9617335
    Abstract: The present invention is an inducible coexpression system, capable of controlled induction of expression of each gene product.
    Type: Grant
    Filed: August 5, 2013
    Date of Patent: April 11, 2017
    Assignee: AbSci LLC
    Inventors: Sean McClain, Mark Valasek
  • Publication number: 20160376602
    Abstract: The present invention provides expression vectors for use in an inducible coexpression system, capable of controlled induction of expression of each gene product.
    Type: Application
    Filed: September 11, 2016
    Publication date: December 29, 2016
    Applicant: AbSci, LLC
    Inventors: Sean McClain, Mark Valasek, Philip Barish, Jeremy Minshull
  • Publication number: 20160152701
    Abstract: The present invention is an inducible coexpression system, capable of controlled induction of expression of each gene product.
    Type: Application
    Filed: November 25, 2015
    Publication date: June 2, 2016
    Applicant: ABSCI, LLC
    Inventors: Sean McClain, Mark Valasek
  • Publication number: 20150353940
    Abstract: The present invention provides expression vectors for use in an inducible coexpression system, capable of controlled induction of expression of each gene product.
    Type: Application
    Filed: June 16, 2015
    Publication date: December 10, 2015
    Applicant: ABSCI, LLC
    Inventors: Sean McClain, Mark Valasek, Philip Barish, Jeremy Minshull